1. Fucoidan Does Not Exert Anti-Tumorigenic Effects on Uveal Melanoma Cell Lines
   Michaela Dithmer et al, 2017, Marine Drugs CrossRef
2. The emerging role of RUNX3 in cancer metastasis (Review)
   FEIFEI CHEN et al, 2016, Oncology Reports CrossRef
3. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab
   Richard I Kaplan et al, 2017, British Journal of Ophthalmology CrossRef
4. Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
   Florian Castet et al, 2019, Cancers CrossRef
5. Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid
   Junwon Lee et al, 2019, BMC Ophthalmology CrossRef
6. ALTERED PARAFOVEAL MICROVASCULATURE IN TREATMENT-NAIVE CHOROIDAL MELANOMA EYES DETECTED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY
   Yafeng Li et al, 2017, Retina CrossRef
7. Growth of Uveal Melanoma following Intravitreal Bevacizumab
   Jasmine H. Francis et al, 2017, Ocular Oncology and Pathology CrossRef
8. RELATIONSHIP OF CLINICAL FEATURES AND BASELINE TUMOR SIZE WITH GENE EXPRESSION PROFILE STATUS IN UVEAL MELANOMA
   Duncan Berry et al, 2019, Retina CrossRef
9. IL-17, IL-23, and p73 expression in cutaneous melanoma
   Giulia Ganzetti et al, 2015, Melanoma Research CrossRef
10. Hypoxia-dependent drivers of melanoma progression
    Simona D’Aguanno et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
11. Central subfield thickness predicts visual acuity outcomes in plaque-irradiated eyes with choroidal melanoma
    Saumya M. Shah et al, 2024, Graefe's Archive for Clinical and Experimental Ophthalmology CrossRef
12. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
    Amir Mahdjoubi et al, 2018, Graefe's Archive for Clinical and Experimental Ophthalmology CrossRef